Michael Kauffman's Net Worth
Michael Kauffman's net worth is estimated to be at least $14,984,299.20 as of 11/22/2024. CoreStreet's estimation of Michael Kauffman's net worth is based on their sale of stock and current holding of stock.
Michael Kauffman is Director at Adicet Bio Inc. They have executed at least 33 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,900 units of ACET stock on 06/05/2024. Their biggest sale was on 07/02/2014 when they sold 200,000 units of Karyopharm Therapeutics Inc stock for $8,500,000.00. They typically trade 4 times per year.
Total value of insider buys:
- $57,260.00
Total value of insider sells:
- $14,927,039.20
Most recent insider trade:
- June 5, 2024
Michael Kauffman's Insider Trading History
| Adicet Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 5, 2024 | Director | 5,900 | $1.43 | Sell | $8,437.00 |
| Karyopharm Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 7, 2022 | Director | 6,764 | $9.86 | Sell | $66,693.04 |
Oct. 12, 2020 | CEO | 7,500 | $14.89 | Sell | $111,675.00 |
Aug. 17, 2020 | CEO | 1,477 | $15.00 | Sell | $22,155.00 |
July 15, 2020 | CEO | 7,500 | $19.43 | Sell | $145,725.00 |
July 9, 2020 | CEO | 7,500 | $19.53 | Sell | $146,475.00 |
June 15, 2020 | CEO | 7,500 | $16.37 | Sell | $122,775.00 |
June 9, 2020 | CEO | 7,500 | $18.50 | Sell | $138,750.00 |
April 8, 2020 | CEO | 10,000 | $18.61 | Sell | $186,100.00 |
Feb. 19, 2020 | CEO | 8,817 | $16.48 | Sell | $145,304.16 |
Jan. 9, 2020 | CEO | 10,000 | $19.19 | Sell | $191,900.00 |
Dec. 9, 2019 | CEO | 10,000 | $17.02 | Sell | $170,200.00 |
Nov. 11, 2019 | CEO | 10,000 | $14.76 | Sell | $147,600.00 |
Nov. 8, 2019 | CEO | 10,000 | $14.63 | Sell | $146,300.00 |
Nov. 1, 2019 | CEO | 20,000 | $14.17 | Sell | $283,400.00 |
Sept. 16, 2019 | CEO | 10,000 | $12.00 | Sell | $120,000.00 |
Nov. 26, 2018 | CEO | 9,600 | $11.00 | Sell | $105,600.00 |
Sept. 18, 2018 | CEO | 10,000 | $18.26 | Sell | $182,600.00 |
Aug. 20, 2018 | CEO | 10,000 | $17.46 | Sell | $174,600.00 |
Aug. 7, 2018 | CEO | 12,500 | $18.04 | Sell | $225,500.00 |
July 18, 2018 | CEO | 10,000 | $18.27 | Sell | $182,700.00 |
May 18, 2018 | CEO | 10,000 | $19.39 | Sell | $193,900.00 |
April 18, 2018 | CEO | 10,000 | $14.79 | Sell | $147,900.00 |
March 19, 2018 | CEO | 10,000 | $15.29 | Sell | $152,900.00 |
Feb. 20, 2018 | CEO | 10,000 | $14.79 | Sell | $147,900.00 |
Jan. 18, 2018 | CEO | 10,000 | $10.09 | Sell | $100,900.00 |
Dec. 18, 2017 | CEO | 10,000 | $9.16 | Sell | $91,600.00 |
Jan. 12, 2015 | CEO | 50,000 | $33.00 | Sell | $1,650,000.00 |
July 2, 2014 | CEO | 200,000 | $42.50 | Sell | $8,500,000.00 |
June 17, 2014 | CEO | 20,000 | $41.76 | Sell | $835,200.00 |
| Kezar Life Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 3, 2022 | Director | 5,000 | $16.45 | Sell | $82,250.00 |
| Verastem Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 28, 2018 | Director | 4,000 | $7.49 | Buy | $29,960.00 |
Sept. 17, 2014 | Director | 3,000 | $9.10 | Buy | $27,300.00 |